Earlier today, Merck (NYSE: MRK) said it is ready to buy larger biotech firms with established sales and late-stage drugs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE